Upload

Dr Michael Nyongesa WALEKHWA

OffLine
Staff Information
PERSONAL DETAILS
Designation
Lecturer - Immunology and Hematology
Department
Department of Biomedical Sciences
Section
School of Medicine & Health Sciences, Main Campus
Address
mwalekhwa@kabarak.ac.ke
ACADEMIC QUALIFICATIONS

 

September 2019-Date   

School of Business & Economics, Kabarak University   

Master of Business Administration (Strategic Management)

 

September 2015-December 2020

School of Medicine & Health Sciences, Kenyatta University

Ph.D. Medical Immunology

 

January 2011-June 2016

School of Medicine & Health Sciences, Kenyatta University

MSc. Infectious Diseases (Immunology Option)

 

January 2004-July 2010

School of Health Sciences, University of Eastern Africa, Baraton

BSc. Medical Laboratory Sciences

 

February 1999- November 2002

Friends High School, Bokoli

Kenya Certificate of Secondary

Education (KCSE B{Plain})

 

 

   

 

LIST OF PUBLICATIONS
  1. Kilimo, S. K., Walekhwa, M. N., & Otieno, F. O. (2022). Impact of health management information systems on service delivery among healthcare workers at Iten County Referral Hospital. Int J Res Med Sci 10:1889-95. https://dx.doi.org/10.18203/2320-6012.ijrms20222264
  2. Nyambega, N. K., Wambugu, E. N., Walekhwa, M. N., & Otieno, F. O. (2022). Effects of COVID-19 Pandemic on the Practice of Community Pharmacy in Kisumu County. European Journal of Medical and Health Sciences, 4(4), 39–43. https://doi.org/10.24018/ejmed.2022.4.4.1377
  3. Matura, J., Walekhwa, M., & Otieno, F. (2022). Larvicidal Activity of the Methanolic Extract of Warbugia ugadensis Seed Oil on Aedes aegypti. Journal of Science, Innovation and Creativity, 1(1), 1–9. Retrieved from https://utafitionline.com/index.php/jsic/article/view/52
  4. Walekhwa, M,. & Otieno, F. (2022). Instructional Immunology – A Textbook for Beginners.1st Edi. Kenya: Utafiti Foundation
  5. Otieno, F., & Walekhwa, M. (2022). Insilco screening of chloroquine analogues for compounds with more affinity for the Plasmodium falciparum chloroquine transporter as potential antimalarial drugs. F1000Research. Accepted
  6. Warugongo, E., Walekhwa, M., Otieno, F., and Yegon, N. (2022). Factors Influencing Male Partner’s Knowledge on Their Role During Antenatal Care in Mangu, Nakuru County. European Journal of Medical & Health Sciences. Accepted
  7. Otieno, F., & Walekhwa, M. (2021). COVID-19 Vaccines Confer a Prophylactic Effect on Common Cold. Kabarak Journal of Research & Innovation, 11(3), 251-256. Retrieved from http://ojs.kabarak.ac.ke/index.php/kjri/article/view/455/162
  8. Kiprotich, D., Yegon, C, N., & Walekhwa, N, M. (2021). Level of Micronutrients Affects Pathophysiology of Diabetes Mellitus: A Scoping Review. European Journal of Medical & Health Sciences, Vol. 3(5). pp.6-13. https://doi.org/10.24018/ejmed.2021.3.5.1019
  9. Kagia, R., Chepkirui, C., Walekhwa, M., Ogeto, T., Suge, T., Murithi, M et al. (2021).
  10. Antimicrobial Activity of Moringa oleifera Leaf Extracts against Streptococcus pneumoniae Isolates. European Journal of Biology & Biotechnology. Vol. 2(4). pp. 28-32. https://doi.org/10.24018/ejbio.2021.2.4.223
  11. Walekhwa, M., Kagia, R., & Muturi, M. (2021). Immune responses to SARS-CoV-2: a scoping review. European Journal of Medical & Health Sciences, Vol 3(2). https://www.ejmed.org/index.php/ejmed/article/view/766           
  12. Walekhwa, M., Muturi, M., Josephat, T., Titus, S., & Beatrice, K. (2021). Comparison of disk-diffusion and E-test methods for in-vitro susceptibility of Streptococcus pneumoniae isolates to oxacillin and ceftriaxone. African Journal of Microbiology Research, 15(1), 69-74. https://doi.org/10.5897/AJMR2020.9356
  13. Ogeto, T; Ndubi, F; Murithi, M; Kagia, R; Wambugu, E; Suge, T; Chepkirui, C; Tonui, J;Maiyo, F; Momanyi, L; & Walekhwa, M. (2020).  Malaria vaccines targeting the pre-erythrocytic stage: a scoping review. F1000Research. https://doi.org/10.12688/f1000research.24320.113. 
  14. Murithi M, Kerubo T, Walekhwa M, Kagia R, Lagat M & Malago, Z. (2020). oral contraceptives and Intrauterine Devices as Risk Factors for Breast and Cervical Cancers: A Systematic Review: International journal of research in medical sciences, 8(6):2350-2359.http://dx.doi.org/10.18203/2320-6012.ijrms20202294
  15. Walekhwa M, Murithi M, Ogeto T and Malago Z (2020). Pharmacological Effects of Sesbania sesban: A Systematic Review. International journal of research in medical sciences, 8(3):1185-1194. http://dx.doi.org/10.18203/2320-6012.ijrms20200803
  16. Walekhwa M and Muturi M. (2020). Risk Factors of Nasopharyngeal PneumococcusCarriage Post PCV-10 Era among Children attending Gertrude’s Children Hospital, Nairobi. Global Scientific Journal: 8(2) 2320-9186. http://www.globalscientificjournal.com/researchpaper/Risk_Factors_of_Nasopharyngeal_Pneumococcus_Carriage_Post_PCV_10_Era_among_Children_Attending_Gertrude_s_Children_Hospital_Nairobi.pdf
  17. Walekhwa M, Muturi M, Kenya E and Kabera B (2019). Streptococcus Pneumoniae serotype specific anti-microbial susceptibility profiles among PCV-10 vaccinated and unvaccinated children attending Gertrude’s Children’s Hospital: a cross-sectional study; F1000Research, 8:1699 https://doi.org/10.12688/f1000research.20486.1
  18. Walekhwa M. Peer Review Report For: Performance characteristics of a modified HIV- 1 drug resistance genotyping method for use in resource-limited F1000Research, 8:1518.https://doi.org/10.5256/f1000research.22050.r53075
  19. Walekhwa M, Muturi M, Gunturu R et al. (2018). Streptococcus pneumoniae Serotype Epidemiology among PCV-10 Vaccinated and Unvaccinated Children at Gertrude’s Children’s Hospital, Nairobi County: a cross-sectional study. F1000Reseach, 7:879. https://doi: 10.12688/f1000research.14387.2 
  20. Walekhwa M, Muturi M and Bukusi E. (2015). Immunogenicity of 10-valent Pneumococcal Conjugate Vaccine among Infants Attending Mbagathi District Hospital. F1000Research, 4(16). https://doi: 10.12688/f1000research.6087.1)

Our Moral Code

As members of Kabarak University family, we purpose at all times and in all places, to set apart in one’s heart, Jesus as Lord. (1 Peter 3:15)